Impact of the COVID-19 pandemic on the occurrence and outcome
of cardiogenic shock complicating acute myocardial infarction

J 2023

Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA, Jiří JARKOVSKÝ et. al.

Základní údaje

Originální název

Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

Autoři

MOTOVSKA, Zuzana (203 Česká republika), Ota HLINOMAZ (203 Česká republika, domácí), Jan MROZEK (203 Česká republika), Petr KALA (203 Česká republika, domácí) a Jiří JARKOVSKÝ (203 Česká republika, domácí)

Vydání

European Journal of Internal Medicine, AMSTERDAM, ELSEVIER, 2023, 0953-6205

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 8.000 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133064

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.ejim.2023.05.032

UT WoS

001073531600001

Klíčová slova anglicky

cardiogenic shock; acute myocardial infarction; COVID-19

Štítky

14110115, 14110132, 14110211, 14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 25. 1. 2024 14:41, Mgr. Tereza Miškechová

Anotace

V originále

SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .

Návaznosti

LX22NPO5104, projekt VaV

Název: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění (Akronym: CarDia)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní institut pro léčbu metabolických a kardiovaskulárních onemocnění, 5.1 EXCELES

NV19-02-00086, projekt VaV

Název: Duální protidestičková léčba pacientů s akutním infarktem myokardu v kardiogenním šoku - studie DAPT-SHOCK AMI

Investor: Ministerstvo zdravotnictví ČR, Duální protidestičková léčba pacientů s akutním infarktem myokardu v kardiogenním šoku - studie DAPT-SHOCK AMI

90249, velká výzkumná infrastruktura

Název: CZECRIN IV

Citovat

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA a Jiří JARKOVSKÝ. Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction. European Journal of Internal Medicine. AMSTERDAM: ELSEVIER, 2023, roč. 115, September 2023, s. 134-136. ISSN 0953-6205. Dostupné z: https://dx.doi.org/10.1016/j.ejim.2023.05.032.

@article{2362117,
   author = {Motovska, Zuzana and Hlinomaz, Ota and Mrozek, Jan and Kala, Petr and Jarkovský, Jiří},
   article_location = {AMSTERDAM},
   article_number = {September 2023},
   doi = {http://dx.doi.org/10.1016/j.ejim.2023.05.032},
   keywords = {cardiogenic shock; acute myocardial infarction; COVID-19},
   language = {eng},
   issn = {0953-6205},
   journal = {European Journal of Internal Medicine},
   title = {Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction},
   url = {https://www.sciencedirect.com/science/article/pii/S095362052300184X?via%3Dihub},
   volume = {115},
   year = {2023}
}

TY  - JOUR
ID  - 2362117
AU  - Motovska, Zuzana - Hlinomaz, Ota - Mrozek, Jan - Kala, Petr - Jarkovský, Jiří
PY  - 2023
TI  - Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
JF  - European Journal of Internal Medicine
VL  - 115
IS  - September 2023
SP  - 134-136
EP  - 134-136
PB  - ELSEVIER
SN  - 09536205
KW  - cardiogenic shock
KW  - acute myocardial infarction
KW  - COVID-19
UR  - https://www.sciencedirect.com/science/article/pii/S095362052300184X?via%3Dihub
N2  - SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .
ER  -

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA a Jiří JARKOVSKÝ. Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction. \textit{European Journal of Internal Medicine}. AMSTERDAM: ELSEVIER, 2023, roč.~115, September 2023, s.~134-136. ISSN~0953-6205. Dostupné z: https://dx.doi.org/10.1016/j.ejim.2023.05.032.

Podrobný výpis o publikaci